Funding Neuro are overjoyed to announce that the phase 1 study of GD2 CAR-T-cells for patients with H3K27M+DMG is now open for recruitment.

This is a single centre study taking place at Great Ormond Street Hospital (GOSH). NHS eligible patients (age 2-16) from throughout the UK who meet the study inclusion criteria can take part. To discuss if this clinical study may be an option for your child or family member and to be referred to discuss taking part in this study, please contact your own consultant oncologist at your local treatment centre.

If you would like to discuss with us please call David on- 0141 674 1941 or email dmulligan@fundingneuro.com